Pediatric asthma: evidence weak for subcutaneous or sublingual immunotherapy

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Because of very low-quality evidence, whether subcutaneous (SCIT) and sublingual immunotherapy (SLIT) are effective in pediatric asthma remains unclear.
  • Authors conclude benefits unlikely to outweigh potential harms.
  • More studies are needed.

Why this matters

  • A 2010 Coch...